USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fresenius Medical Care Deutschland GmbH

USPTO PatentsView assignee record — 615 granted patents across 125 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

615
Total patents granted
125
CPC technology areas
16.1
Avg claims per patent
+7%
5-year filing velocity

Portfolio overview

Fresenius Medical Care Deutschland GmbH has been granted 615 US utility patents between 2015 and 2025, placing Fresenius Medical Care Deutschland GmbH at rank #743 across all assignees tracked by PlainPatent. This portfolio spans 125 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Fresenius Medical Care Deutschland GmbH is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 318 grants, compared with 297 in the 2015–2019 window — a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Fresenius Medical Care Deutschland GmbH's 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fresenius Medical Care Deutschland GmbH against peers pursuing similar technology classes.

How does Fresenius compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Fresenius holds 615 patents — placing it at rank #743 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

3040506070 20152016201720182019202020212022202320242025 42
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Fresenius Medical Care Deutschland GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 46 7.5%
2016 65 10.6%
2017 67 10.9%
2018 52 8.5%
2019 67 10.9%
2020 60 9.8%
2021 49 8.0%
2022 63 10.2%
2023 37 6.0%
2024 67 10.9%
2025 42 6.8%

Which technologies does Fresenius Medical Care Deutschland GmbH patent most?

Top 15 of 125 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Diversified
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#743

Across all tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Fresenius Medical Care Deutschland GmbH hold?
Fresenius Medical Care Deutschland GmbH holds 615 US granted patents filed between 2015 and 2025, spanning 125 technology areas.
What is Fresenius Medical Care Deutschland GmbH's Innovation Score?
Fresenius Medical Care Deutschland GmbH has an Innovation Score of 63.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Fresenius Medical Care Deutschland GmbH focus on?
Fresenius Medical Care Deutschland GmbH's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 539 patents. The company has filed patents in 125 CPC subclasses total.
Is Fresenius Medical Care Deutschland GmbH's patent filing rate increasing or decreasing?
Fresenius Medical Care Deutschland GmbH's recent filing velocity is +7% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Fresenius Medical Care Deutschland GmbH's patents?
Fresenius Medical Care Deutschland GmbH's patents average 16.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Fresenius Medical Care Deutschland GmbH patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope